Aral F - Search Results

1

Lactobacillus GG is associated with mucin genes expressions in type 2 diabetes mellitus: a randomized, placebo-controlled trial.

Eliuz Tipici B, Coskunpinar E, Altunkanat D, Cagatay P, Omer B, Palanduz S, Satman I, Aral F. Eliuz Tipici B, et al. Among authors: aral f. Eur J Nutr. 2023 Aug;62(5):2155-2164. doi: 10.1007/s00394-023-03139-3. Epub 2023 Mar 30. Eur J Nutr. 2023. PMID: 36997822 Clinical Trial.

2

Risk factors of incidental parathyroidectomy after thyroidectomy for benign thyroid disorders.

Erbil Y, Barbaros U, Ozbey N, Aral F, Ozarmağan S. Erbil Y, et al. Among authors: aral f. Int J Surg. 2009 Feb;7(1):58-61. doi: 10.1016/j.ijsu.2008.10.012. Epub 2008 Oct 25. Int J Surg. 2009. PMID: 19027373 Free article.

3

Pituitary macroadenoma in Addison's disease.

Akçay G, Aral F, Ozbey N, Azezli A, Orhan Y, Sencer E, Molvalilar S. Akçay G, et al. Among authors: aral f. J Int Med Res. 1996 Mar-Apr;24(2):221-7. doi: 10.1177/030006059602400207. J Int Med Res. 1996. PMID: 8737233

4

Clinical laboratory findings and results of therapy in 55 patients with Cushing's syndrome.

Erem C, Algün E, Ozbey N, Azezli A, Aral F, Orhan Y, Molvalilar S, Sencer E. Erem C, et al. Among authors: aral f. J Endocrinol Invest. 2003 Jan;26(1):65-72. doi: 10.1007/BF03345125. J Endocrinol Invest. 2003. PMID: 12602537

5

Utility of baseline serum phosphorus levels for predicting remission in acromegaly patients.

Yalin GY, Tanrikulu S, Gul N, Uzum AK, Aral F, Tanakol R. Yalin GY, et al. Among authors: aral f. J Endocrinol Invest. 2017 Aug;40(8):867-874. doi: 10.1007/s40618-017-0657-3. Epub 2017 Mar 29. J Endocrinol Invest. 2017. PMID: 28357781

6

Calcitriol treatment in patients with low vitamin D levels.

Tanakol R, Gül N, Üzüm AK, Aral F. Tanakol R, et al. Among authors: aral f. Arch Osteoporos. 2018 Oct 23;13(1):114. doi: 10.1007/s11657-018-0529-2. Arch Osteoporos. 2018. PMID: 30353299 Clinical Trial.

7

Effect of Cabergoline Treatment on Disease Control in Acromegaly Patients.

Hacisahinogullari H, Yalin GY, Selcukbiricik OS, Gul N, Bilgic B, Uzum AK, Tanakol R, Aral F. Hacisahinogullari H, et al. Among authors: aral f. Horm Metab Res. 2022 Oct;54(10):664-670. doi: 10.1055/a-1930-6585. Epub 2022 Oct 7. Horm Metab Res. 2022. PMID: 36206759 Free article.

8

Thyroid hormone resistance with succinate dehydrogenase-B gene mutation.

Erel C, Cakmak R, Hacisahinogullari H, Artan S, Kubat Uzum A, Aral F, Tanakol R, Yazici H. Erel C, et al. Among authors: aral f. Minerva Endocrinol (Torino). 2022 Jun;47(2):137-139. doi: 10.23736/S2724-6507.21.03602-2. Epub 2021 Nov 26. Minerva Endocrinol (Torino). 2022. PMID: 34825555 Free article. No abstract available.

9

Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer.

Goksoy Solak Y, Yegen G, Onder S, Tekin S, Soyluk O, Gul N, Tanakol R, Aral F, Kubat Uzum A. Goksoy Solak Y, et al. Among authors: aral f. Endocrine. 2023 Nov;82(2):353-360. doi: 10.1007/s12020-023-03427-2. Epub 2023 Jun 20. Endocrine. 2023. PMID: 37340285

10

Prevalence of papillary thyroid cancer in subacute thyroiditis patients may be higher than it is presumed: retrospective analysis of 137 patients.

Gül N, Üzüm AK, Selçukbiricik ÖS, Yegen G, Tanakol R, Aral F. Gül N, et al. Among authors: aral f. Radiol Oncol. 2018 Sep 11;52(3):257-262. doi: 10.2478/raon-2018-0027. Radiol Oncol. 2018. PMID: 30210035 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page